glp 1 and gip agonist TrimRX Curious about the latest in

Psychiatry 6 , e809 (2016)

By addressing multiple pathophysiological pathways, including insulin resistance, inflammation, and oxidative stress, Tirzepatide presents a unique opportunity to redefine treatment paradigms beyond glycemic management

A newer version of phentermine (combining phentermine with topiramate in one pill) was approved for chronic weight management in adults and kids down to age 12 in 2012 and marketed as Qsymia

The BPL1 postbiotic supports metabolic outcomes at a cellular level

The 2 result did not identify any high heterogeneity in the network, and most comparisons were low or low-moderate levels of heterogeneity (appendix 5)

After adjustment of the model for weight loss, associations between the groups and headache outcomes did not remain statistically significant although a trend towards better headache outcomes in the GLP-1-RA group was noted